$ABEO
ABEONA THERAPEUTICS INC. Stock $abeo

$abeo Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-K Financial Statement

#000114420418015277 Filed on March 16, 2018

Income Statement

Concept	2018 Q1	2016 Q4	2016
Revenue	$531.0K	$260.0K	$889.0K
YoY Change	185.48%	18.18%	-14.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.880M	$2.800M	$13.29M
YoY Change	-4.64%	-34.12%	-7.19%
% of Gross Profit
Research & Development	$8.162M	$3.040M	$10.66M
YoY Change	271.34%	46.86%	125.74%
% of Gross Profit
Depreciation & Amortization	$174.0K	$250.0K	$825.0K
YoY Change	-30.4%	66.67%	50.0%
% of Gross Profit
Operating Expenses	$8.162M	$6.090M	$10.66M
YoY Change	271.34%	-5.87%	-45.61%
Operating Profit	-$10.68M		-$23.88M
YoY Change	102.18%
Interest Expense	$150.0K	-$1.170M	$2.010M
YoY Change	275.0%	-129.92%	-50.0%
% of Operating Profit
Other Income/Expense, Net	$153.0K		$2.008M
YoY Change	313.51%
Pretax Income	-$10.53M	-$7.000M	-$21.87M
YoY Change	100.57%	199.15%	50.52%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$10.53M	-$7.000M	-$21.87M
YoY Change	100.69%	199.15%	50.54%
Net Earnings / Revenue	-1983.05%	-2692.31%	-2460.4%
Basic Earnings Per Share
Diluted Earnings Per Share	-$223.8K	-$184.6K	-$639.8K
COMMON SHARES
Basic Shares Outstanding	47.23M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q1	2016 Q4	2016
SHORT-TERM ASSETS
Cash & Short-Term Investments	$132.0M	$69.10M	$69.10M
YoY Change	108.86%	72.32%	72.32%
Cash & Equivalents	$132.0M	$69.14M	$69.10M
Short-Term Investments
Other Short-Term Assets	$2.100M	$200.0K	$200.0K
YoY Change	320.0%	-33.33%	-33.33%
Inventory
Prepaid Expenses
Receivables	$100.0K	$100.0K	$100.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$134.2M	$69.42M	$69.40M
YoY Change	110.27%	70.99%	70.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.789M	$721.0K	$700.0K
YoY Change	584.14%	80.25%	75.0%
Goodwill	$32.47M	$32.47M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$400.0K	$100.0K	$100.0K
YoY Change	300.0%	0.0%	0.0%
Total Long-Term Assets	$41.50M	$41.64M	$41.70M
YoY Change	0.0%	5.41%	5.57%
TOTAL ASSETS
Total Short-Term Assets	$134.2M	$69.42M	$69.40M
Total Long-Term Assets	$41.50M	$41.64M	$41.70M
Total Assets	$175.7M	$111.1M	$111.1M
YoY Change	66.81%	38.65%	38.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.910M	$3.694M	$3.700M
YoY Change	294.0%	310.44%	311.11%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.393M	$8.296M	$8.300M
YoY Change	-60.77%	453.07%	453.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$3.700M	$3.700M
YoY Change	-100.0%	-66.06%	-66.06%
Total Long-Term Liabilities	$0.00	$3.700M	$3.700M
YoY Change	-100.0%	-66.06%	-66.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.393M	$8.296M	$8.300M
Total Long-Term Liabilities	$0.00	$3.700M	$3.700M
Total Liabilities	$2.393M	$11.96M	$12.00M
YoY Change	-75.07%	-2.76%	-2.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$353.5M	-$332.5M
YoY Change
Common Stock	$533.8M	$431.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$169.7M	$99.10M	$99.10M
YoY Change
Total Liabilities & Shareholders Equity	$175.7M	$111.1M	$111.1M
YoY Change	66.81%	38.65%	38.7%

Cashflow Statement

Concept	2018 Q1	2016 Q4	2016
OPERATING ACTIVITIES
Net Income	-$10.53M	-$7.000M	-$21.87M
YoY Change	100.69%	199.15%	50.54%
Depreciation, Depletion And Amortization	$174.0K	$250.0K	$825.0K
YoY Change	-30.4%	66.67%	50.0%
Cash From Operating Activities	-$4.082M	-$3.390M	-$13.01M
YoY Change	-30.31%	18.12%	24.89%
INVESTING ACTIVITIES
Capital Expenditures	$3.502M	-$20.00K	$519.0K
YoY Change	4632.43%	-92.59%	-267.42%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$3.502M	-$20.00K	-$519.0K
YoY Change	4632.43%	-92.59%	-115.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.829M	41.37M	42.54M
YoY Change	182800.0%		19.32%
NET CHANGE
Cash From Operating Activities	-4.082M	-3.390M	-13.01M
Cash From Investing Activities	-3.502M	-20.00K	-519.0K
Cash From Financing Activities	1.829M	41.37M	42.54M
Net Change In Cash	-5.755M	37.96M	29.00M
YoY Change	-2.95%	-1308.92%	1.34%
FREE CASH FLOW
Cash From Operating Activities	-$4.082M	-$3.390M	-$13.01M
Capital Expenditures	$3.502M	-$20.00K	$519.0K
Free Cash Flow	-$7.584M	-$3.370M	-$13.53M
YoY Change	27.87%	29.62%	33.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2017Q2	dei	Entity Public Float EntityPublicFloat	162488000	USD
CY2017	dei	Trading Symbol TradingSymbol	ABEO
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47226940	shares
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	137750000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69142000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	107000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	124000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2735000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	155000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	140592000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	69421000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1374000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	721000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3977000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8384000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	32466000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	32466000	USD
CY2017Q4	us-gaap	Assets Assets	178766000	USD
CY2016Q4	us-gaap	Assets Assets	111058000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2393000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3694000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3214000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	602000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5607000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8296000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3061000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3664000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	8668000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	11960000	USD
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue	235000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	287000	USD
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	837000	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	889000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16989000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10655000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10943000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13290000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	741000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	825000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	28673000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	24770000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-27836000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-23881000	USD
CY2017	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	525000	USD
CY2016	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2014000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-27319000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	92403000	USD
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40254457	shares
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2008000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-21873000	USD
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46888108	shares
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.66
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.64
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41636752	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34180253	shares
CY2017	abeo	Interest And Other Expense InterestAndOtherExpense	8000	USD
CY2016	abeo	Interest And Other Expense InterestAndOtherExpense	6000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40138000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4644000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4829000	USD
CY2017	abeo	Allocated Share Based Compensation Expense Restricted Stock AllocatedShareBasedCompensationExpenseRestrictedStock	1272000	USD
CY2016	abeo	Allocated Share Based Compensation Expense Restricted Stock AllocatedShareBasedCompensationExpenseRestrictedStock	3432000	USD
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-17000	USD
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	9000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2580000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-160000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2591000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2009000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-602000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22935000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13014000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	860000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	519000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-860000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-519000	USD
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	150000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	344000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	350000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42537000	USD
CY2017	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4000000	USD
CY2016	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2017	abeo	Significantnoncashtransactionvalueofsharesissued Significantnoncashtransactionvalueofsharesissued	0	USD
CY2016	abeo	Significantnoncashtransactionvalueofsharesissued Significantnoncashtransactionvalueofsharesissued	0	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="FONT-WEIGHT: normal"><u>Use of Estimates</u></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 13.5pt; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amount of assets and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from these estimates and assumptions.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	0	USD
CY2017	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	127000	USD
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8508177	shares
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	68608000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	29004000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	8000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	6000	USD
CY2017	abeo	Stock Issued For Licenses StockIssuedForLicenses	0	USD
CY2016	abeo	Stock Issued For Licenses StockIssuedForLicenses	2452000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	67721000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4829000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4644000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	350000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	344000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	150000	USD
CY2016	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2452000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9289000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-7437000	USD
CY2017	abeo	Incometax Reconciliation Current Year Reserve IncometaxReconciliationCurrentYearReserve	-25175000	USD
CY2016	abeo	Incometax Reconciliation Current Year Reserve IncometaxReconciliationCurrentYearReserve	7423000	USD
CY2016	abeo	Increase Decrease In Other Assets And Restricted Cash IncreaseDecreaseInOtherAssetsAndRestrictedCash	4000	USD
CY2017	abeo	Increase Decrease In Other Assets And Restricted Cash IncreaseDecreaseInOtherAssetsAndRestrictedCash	291000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1301000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2819000	USD
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8364412	shares
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	46000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	14000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	34418000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46888108	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40254457	shares
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	50029000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	73864000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	3227000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	2557000	USD
CY2017Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	3089000	USD
CY2016Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	3089000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	28000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	23000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5122000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6450000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	57000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	92000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	778000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1464000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	379000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	228000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	156000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	253000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	143000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	231000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	62838000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	88021000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	62838000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	88021000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	238235000	USD
CY2016Q4	abeo	New Issues Share Price Per Share NewIssuesSharePricePerShare	3.27
CY2016Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5
CY2017Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	2654000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2017Q4	us-gaap	Grants Receivable GrantsReceivable	13875000	USD
CY2017	us-gaap	Revenue From Grants RevenueFromGrants	2600000	USD
CY2017	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	525000	USD
CY2016	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2014000	USD
CY2017	abeo	Number Of Years Subject To Statute Of Limitations By Major Tax Jurisdiction NumberOfYearsSubjectToStatuteOfLimitationsByMajorTaxJurisdiction	P3Y
CY2017	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	18000	USD
CY2016	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	18000	USD
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	455000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	0	USD
CY2017	abeo	Number Of Investment Options NumberOfInvestmentOptions	50	pure
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1760000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	900000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	179000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	386000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	207000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	148000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4608000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9608000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	631000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1224000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	629000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	809000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	814000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	820000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	825000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1015000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4912000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	742000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	548000	USD
CY2017	abeo	Licensed Technology LicensedTechnology	127000	USD
CY2017Q4	us-gaap	Other Commitment OtherCommitment	231000	USD
CY2017	abeo	Lease Extension Period LeaseExtensionPeriod	P5Y
CY2017Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5750000	shares
CY2017Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	16.00
CY2017Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	92000000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5000000	USD
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.00
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	900000	USD
CY2016Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.00
CY2017Q4	abeo	Other Assetsand Restricted Cash OtherAssetsandRestrictedCash	357000	USD
CY2016Q4	abeo	Other Assetsand Restricted Cash OtherAssetsandRestrictedCash	66000	USD
CY2017Q4	abeo	Payable Due Licensor Current PayableDueLicensorCurrent	0	USD
CY2016Q4	abeo	Payable Due Licensor Current PayableDueLicensorCurrent	4000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	346000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	346000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	346000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	346000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	346000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2247000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	534000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	677000	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2934685	shares

Files In Submission

Name	View Source	Status
0001144204-18-015277-index-headers.html	Edgar Link	pending
0001144204-18-015277-index.html	Edgar Link	pending
0001144204-18-015277.txt	Edgar Link	pending
0001144204-18-015277-xbrl.zip	Edgar Link	pending
abeo-20171231.xml	Edgar Link	completed
abeo-20171231.xsd	Edgar Link	pending
abeo-20171231_cal.xml	Edgar Link	unprocessable
abeo-20171231_def.xml	Edgar Link	unprocessable
abeo-20171231_lab.xml	Edgar Link	unprocessable
abeo-20171231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv488183_10k.htm	Edgar Link	pending
tv488183_ex21.htm	Edgar Link	pending
tv488183_ex23-1.htm	Edgar Link	pending
tv488183_ex31-1.htm	Edgar Link	pending
tv488183_ex31-2.htm	Edgar Link	pending
tv488183_ex32.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ABEO
ABEONA THERAPEUTICS INC. Stock $abeo

2018 Q1 Form 10-K Financial Statement

#000114420418015277 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ABEO ABEONA THERAPEUTICS INC. Stock $abeo

2018 Q1 Form 10-K Financial Statement

#000114420418015277 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ABEO
ABEONA THERAPEUTICS INC. Stock $abeo